PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'FORWARD, The National Databank for Rheumatic Diseases, Wichita, Kansas, University of Nebraska Medical Center, Omaha.\', \'FORWARD, The National Databank for Rheumatic Diseases, Wichita, Kansas.\', \'Pfizer Inc., Peapack, New Jersey.\', \'University of California, San Francisco.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/acr.24611
?:hasPublicationType
?:journal
  • Arthritis care & research
is ?:pmid of
?:pmid
?:pmid
  • 33787086
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Changes in Disease-Modifying Antirheumatic Drug Treatment for Patients With Rheumatoid Arthritis in the US During the COVID-19 Pandemic: A Three-Month Observational Study.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all